ARCHIVES

Fondaparinux Prevents DVT In Acutely III Medical Patients

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008

In Brief: Center wins $10 Million To coordinate Study; Albert Einstein Center Name Comprehensive

December 5, 1997

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997